0001816829-25-000002.txt : 20250711 0001816829-25-000002.hdr.sgml : 20250711 20250711084336 ACCESSION NUMBER: 0001816829-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250711 DATE AS OF CHANGE: 20250711 EFFECTIVENESS DATE: 20250711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HighVista Biotechnology Opportunities Fund LP CENTRAL INDEX KEY: 0001816829 ORGANIZATION NAME: EIN: 851099620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-371199 FILM NUMBER: 251117596 BUSINESS ADDRESS: STREET 1: C/O HIGHVISTA STRATEGIES LLC STREET 2: 200 CLARENDON STREET, 50TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 406-6500 MAIL ADDRESS: STREET 1: C/O HIGHVISTA STRATEGIES LLC STREET 2: 200 CLARENDON STREET, 50TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D/A 1 primary_doc.xml X0708 D/A LIVE 0001816829 HighVista Biotechnology Opportunities Fund LP C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR BOSTON MA MASSACHUSETTS 02116 (617) 406-6500 DELAWARE None None Limited Partnership true 2020 N/A HighVista GP VII Limited Partnership c/o HighVista Strategies LLC 200 Clarendon Street, 50th Floor Boston MA MASSACHUSETTS 02116 Executive Officer General Partner of the Issuer. N/A HighVista Strategies LLC 200 Clarendon Street 50th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Investment Manager of the Issuer. Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001816829-24-000001 2020-07-01 true true false 500000 Indefinite 434868951 Indefinite false 50 0 0 0 false HighVista Biotechnology Opportunities Fund LP /s/ Ronald Landen Ronald Landen General Counsel and Secretary of the GP of the GP 2025-07-11